What is the normal serum iron saturation range and how should low or high values be managed?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 21, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Iron Saturation: Normal Range and Management

Normal transferrin saturation (TSAT) ranges from approximately 20-50% in healthy adults, with values below 20% indicating iron deficiency and values above 50% raising concern for iron overload. 1, 2

Normal Reference Ranges

The interpretation of iron saturation varies significantly by demographic factors:

  • General population: Mean TSAT approximately 25-30% 1, 3
  • Gender differences: Males typically have 15-20% higher TSAT levels than females between ages 20-70 1
  • Age considerations: TSAT rises slightly until teen years, then stabilizes in females while continuing to increase in males 1
  • Race variations: Black participants demonstrate lower serum iron and TSAT but higher ferritin compared to White participants 2

Management of Low Iron Saturation (TSAT <20%)

Diagnostic Thresholds

TSAT <20% indicates iron deficiency and warrants intervention, particularly when accompanied by supporting laboratory findings 4. The diagnostic approach differs based on clinical context:

In Healthy Individuals

  • TSAT <16% with ferritin <12 ng/mL defines absolute iron deficiency 4
  • TSAT <20% with ferritin <30 ng/mL indicates depleted iron stores 5, 6

In Inflammatory Conditions

Ferritin becomes unreliable as an isolated marker in inflammatory states (IBD, CHF, CKD) because it acts as an acute-phase reactant 7. In these patients:

  • Use ferritin <100 μg/L OR TSAT <20% to diagnose iron deficiency 7
  • If ferritin is 100-300 μg/L, TSAT <20% is required to confirm iron deficiency 7

Treatment Approach for Low TSAT

Chronic Kidney Disease Patients

Maintain TSAT ≥20% and ferritin ≥100 ng/mL to support adequate erythropoiesis 4. The evidence strongly supports:

  • Intravenous iron is superior to oral iron in hemodialysis patients receiving erythropoietin 4
  • Target TSAT should be maintained at ≥20% but avoid chronically exceeding 50% 4
  • Monitor TSAT and ferritin every 3 months once target hemoglobin is achieved 4
  • Functional iron deficiency can exist even with TSAT ≥20%, particularly in patients requiring high erythropoietin doses 4

A recent study suggests even lower targets may be optimal: serum ferritin <90 ng/mL with TSAT ≥20% achieved adequate hemoglobin levels in hemodialysis patients, potentially reducing iron-related oxidative stress 8.

General Population

Oral iron supplementation is first-line unless contraindications exist 9, 10:

  • Ferrous salts (sulfate, fumarate, gluconate) are reasonable initial choices
  • Better absorbed on empty stomach, though taking with meals improves tolerance
  • Adding 500 mg vitamin C enhances absorption 9

Intravenous iron indications 9, 10:

  • Severe iron deficiency
  • Oral iron intolerance or failure
  • Malabsorption conditions (celiac disease, IBD)
  • Chronic kidney disease
  • Chemotherapy-induced anemia

Management of High Iron Saturation (TSAT >50%)

Hemochromatosis Screening

TSAT >45-50% warrants evaluation for hereditary hemochromatosis, particularly in Caucasians 11. The diagnostic pathway:

  • Confirm with repeat fasting TSAT and ferritin
  • TSAT persistently >45% with elevated ferritin (>200-300 μg/L in women, >300 μg/L in men) suggests hemochromatosis 11
  • Proceed to HFE genetic testing (C282Y and H63D mutations)

Treatment of Iron Overload

Phlebotomy is the definitive treatment for hemochromatosis 11, 12:

Induction Phase

  • Weekly or biweekly phlebotomy (500 mL) until ferritin reaches 50-100 μg/L 11, 12
  • Check hemoglobin/hematocrit before each phlebotomy
  • Avoid reducing hemoglobin by >20% from baseline 11
  • Monitor ferritin every 10-12 phlebotomies 11

Maintenance Phase

  • Target ferritin 50-100 μg/L with flexible interpretation 12
  • Frequency varies: monthly to several times yearly depending on iron reaccumulation rate 11
  • TSAT should be monitored as it reflects non-transferrin-bound iron (NTBI), which drives tissue damage 13
  • Consider maintaining TSAT <50-60% during maintenance 12, 13

Critical Caveats

In CKD patients receiving IV iron: Temporarily withhold iron if TSAT exceeds 50% or ferritin exceeds 800 ng/mL to avoid iron overload 4. There is no known risk with TSAT ≤50%, but no physiologic rationale exists for maintaining TSAT >50% 4.

Avoid vitamin C supplements in iron-loaded patients, especially during phlebotomy, as it accelerates iron mobilization and may increase oxidative stress 11.

In hemochromatosis with advanced cardiac disease: Rapid iron mobilization increases risk of sudden death due to toxic low-molecular-weight iron chelates 11.

References

Related Questions

What is the likely diagnosis and appropriate management for a patient with serum iron 30 µg/dL, ferritin 118 ng/mL, transferrin saturation (TSAT) 18 %, total iron‑binding capacity (TIBC) 169 µg/dL, and unsaturated iron‑binding capacity (UIBC) 139 µg/dL?
Given a patient with ferritin 10 ng/mL, serum iron 36 µg/dL, total iron‑binding capacity (TIBC) 445 µg/dL, transferrin saturation 8 %, and unsaturated iron‑binding capacity (UBC) 409 µg/dL, what medication should be started?
What is the differential diagnosis and recommended management for a patient with high serum iron, high transferrin saturation, and low ferritin?
Is a transferrin saturation of 62% and serum iron of 178 µg/dL concerning, and what are the possible causes?
What is the next step in management for a patient with transferrin saturation of 6 %, ferritin of 6 ng/mL, total iron‑binding capacity of 371 µg/dL, and serum iron of 21 µg/dL?
What renal function criteria determine cisplatin eligibility and how should the dose be adjusted based on creatinine clearance?
Does constipation in children affect their psychological health in the future?
Which specialist should I refer a patient with an umbilical hernia to?
What dose of sotalol can be given to a 6‑kg child with normal renal function who has supraventricular arrhythmias?
Can tamoxifen be used to treat gynecomastia in males, and what is the recommended dosing regimen?
Which antibiotic is effective against Staphylococcus capitis?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.